<DOC>
	<DOCNO>NCT02166502</DOCNO>
	<brief_summary>The purpose study determine whether current dose nevirapine recommend Ontario Ministry Health vertical transmission prevention protocol achieve therapeutic drug level newborn infant high risk HIV infection .</brief_summary>
	<brief_title>Nevirapine Dosing Neonates Prophylaxis Mother-to-Child-Transmission ( MTCT ) HIV Infection</brief_title>
	<detailed_description>Although nevirapine ( NVP ) often give part combination antiretroviral therapy ( cART ) institution prevention vertical transmission ( VT ) high risk infant , optimal prophylactic dose nevirapine unknown . The National Institute Health ( NIH ) guideline currently recommend single 2 mg/kg dose nevirapine give infant within 72 hour birth , however , dose use practice give controversy previously describe single-dose nevirapine . In absence guidance inform multiple daily dose nevirapine prophylaxis VT , currently use treatment dose infant &gt; 15 day age 150 mg/m2 daily 14 day , increase 150 mg/m2 twice daily 14 day . This analogous treatment dose triple antiretrovirals ( ARVs ) give occupational post-exposure prophylaxis . Nevirapine give 4 week total zidovudine ( AZT ) lamivudine ( 3TC ) , follow 2 additional week AZT 3TC prevent development nevirapine resistance long half life . Stopping 3 drug simultaneously would result period functional NVP monotherapy , result risk NVP resistance infant become infected despite prophylaxis . Since dose nevirapine use clinic population prevention VT high previously study neonate , important evaluate safety efficacy dose regimen , use therapeutic drug monitoring .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Newborn infant prescribe combination antiretroviral treatment nevirapine prevention mothertochild HIV transmission . These infant routinely refer Hospital Sick Children ( SickKids ) Children 's Hospital Eastern Ontario ( CHEO ) HIV clinic Toronto Ottawa , respectively , ongoing management . The majority referral Mount Sinai Hospital St. Michael 's Hospital Toronto , Ottawa General Hospital Ottawa . Voluntary inform consent legal guardian Infants bear prior 32 week gestational age ; Infants lifethreatening medical condition ; Infants unable take oral medication ; Infants bear woman consider high risk harbor nevirapine resistance mutation Kaletra ( lopinavir/ritonavir ) therapeutic option ( e.g . term neonate ) exclude prescribed Kaletra rather nevirapine</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>pediatric</keyword>
	<keyword>HIV</keyword>
	<keyword>prevention</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>nevirapine</keyword>
</DOC>